glp 1 patches microneedling Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment' with Advanced Microneedle Technology for Sustained Weekly Efficacy Single-Administration Self-Boosting Microneedle Patch for

In the STEP 1 trial, about 20% of the weight lost on GLP-1s was muscle, not just fat, as shown in research

This stacking behavior complicates medication reconciliation and increases uncertainty surrounding glycemic stability, fluid shifts, and inflammatory response

[15] Serious but rare adverse effects require awareness: Pancreatitis: Acute pancreatitis is a rare but serious potential risk

No serious adverse events were reported, and no participants discontinued the study due to adverse effects

July 21, 2023

Direct GH injections introduce exogenous growth hormone, creating sustained, supraphysiological levels that bypass the bodys regulatory mechanisms